Continuation of the Costa Rican Epidemiologic Surveillance for Invasive Pneumococcal Disease After Introduction of the Seven Valent Vaccine Into the Universal Vaccination Program.

Trial Profile

Continuation of the Costa Rican Epidemiologic Surveillance for Invasive Pneumococcal Disease After Introduction of the Seven Valent Vaccine Into the Universal Vaccination Program.

Suspended
Phase of Trial: Phase IV

Latest Information Update: 16 May 2014

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Mar 2014 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.
    • 25 Mar 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
    • 05 Dec 2011 Planned end date changed from 1 Jul 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top